As a dual inhibitor of PI3K and mTOR, NVP-BEZ235 has shown to induce autophagy in multiple myeloma cells (Ma et al., 2019), colorectal cancer cells (Oh et al., 2016), and esophageal cancer cells (Wu et al., 2018). This evidence concerns the gene MTOR and plasma cell myeloma.